TrialDiabetes care2011

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.

Jaime Uribarri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.